Viewing Study NCT05764057

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-05-28 @ 5:23 AM
Study NCT ID: NCT05764057
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2023-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None AMI View
None STEMI View
None NSTEMI View
None Left Ventricular Dysfunction View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute myocardial infarction View
None Left ventricular dysfunction View
None Dapagliflozin View
None Transthoracic echocardiography View
None Cardiac remodeling View
None Cardiovascular Intensive Care Unit (CICU) View